Fox NewsStem Cell Transplant: Physical, Mental Health Burdens PersistInternal Medicine News Digital NetworkSAN DIEGO – Long after the event, hematopoietic stem cell recipients still bear a heavier burden of physical and emotional problems than do the…
ASH: Rituximab Dosing Schemes Prove Equal in Low-Burden FLMedPage TodayExplain that maintenance therapy with rituximab (Rituxan) in low-burden follicular lymphoma provided disease control that was as good as rituximab retreatment at progression. Point …
Rituximab and Liposomal Doxorubicin Improve Progression-Free and Overall …Monthly Prescribing ReferenceSAN DIEGO, CA—At the 53rd American Society of Hematology Annual Meeting and Exposition, study investigators presented evidence demonstrating prom…
Blood donation day at local female collegeSaudi GazetteBy Doha Ghouth JEDDAH – To help others and raise awareness about donating blood, the female branch of the College of Business Administration (CBA) is hosting a Blood Donation Day today, in cooper…
PBSCs from unrelated donors associated with higher rates of chronic GVHDHemOncTodayWhile PBSCs from related donors have been shown to have clinical benefit, Anasetti told HemOnc Today that these results show that PSBCs from unrelated donors put patient…
R-BAC Effective In Patients With Mantle Cell Lymphoma Not Eligible for …Monthly Prescribing ReferenceSAN DIEGO, CA—The rituximab, bendamustine, and cytarabine (R-BAC) chemotherapy regimen was shown to be effective in previously untreated patients &…
Rituximab Plus Pulse Dexamethasone Effective, Tolerable in Patients with …Monthly Prescribing ReferenceSAN DIEGO, CA—Standard-dose rituximab plus multiple courses of pulse dexamethasone was shown to be active with manageable toxicity in patients wi…
Study Favors As-Needed Treatment Over Maintenance Therapy for Patients with …NEWS.GNOM.ES (press release)ES/ – Asymptomatic patients diagnosed with nonbulky follicular lymphoma, a slow-growing type of non-Hodgkin lymphoma, have traditionally been w…
ASH 2011 Multiple Myeloma Update – Day OneThe Myeloma BeaconThe second is maintenance therapy, which is longer-term therapy that patients often receive after induction therapy and (usually) a stem cell transplant. Dr. Reece explained that a large num…
Emerging Lymphoma and Myeloma Treatments Focus on Improving Individual Patient …PR Newswire (press release)The first clinical trial to directly compare rituximab with the new anti-CD20 monoclonal antibody obinutuzumab for the treatment of relapsed no…